ASX - Delayed Quote AUD
Paradigm Biopharmaceuticals Limited (PAR.AX)
0.3250
-0.0300
(-8.45%)
As of 2:45:15 PM GMT+10. Market Open.
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 47.93M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
Rennie (Paul) Managing Director | -- | Direct | -- | Nov 21, 2024 |
Rennie (Paul) Managing Director | Purchase at price 0.14 per share. | Direct | 13,494 | Oct 15, 2024 |
Fry (Matthew James) Director (Non-Executive) | Purchase at price 0.14 per share. | Direct | 28,740 | Oct 14, 2024 |
Fry (Matthew James) Director (Non-Executive) | Purchase at price 0.14 per share. | Direct | 20,550 | Oct 10, 2024 |
Rennie (Paul) Managing Director | Purchase at price 0.14 per share. | Direct | 20,670 | Oct 10, 2024 |
Fisher (Helen) Retired | -- | Direct | -- | Mar 4, 2024 |
Fry (Matthew James) Director (Non-Executive) | -- | Direct | -- | Mar 4, 2024 |
Fisher (Helen) Director (Non-Executive) | Other at price 0.28 per share. | Direct | 289 | Nov 30, 2023 |
Rennie (Paul) Managing Director | -- | Direct | -- | Nov 30, 2023 |
Rennie (Paul) Managing Director | -- | Direct | -- | Nov 30, 2023 |
Fisher (Helen) Director (Non-Executive) | Purchase at price 0.65 per share. | Direct | 6,629 | May 18, 2023 |
Related Tickers
MEM.AX Memphasys Limited
0.0060
+20.00%
DXB.AX Dimerix Limited
0.5850
-0.85%
TYP.AX TRYPTAMINE FPO [TYP]
0.0370
0.00%
RAD.AX Radiopharm Theranostics Limited
0.0230
+4.55%
BOT.AX Botanix Pharmaceuticals Limited
0.3900
-2.50%
IMM.AX Immutep Limited
0.3000
+7.14%
IMU.AX Imugene Limited
0.0220
-4.35%
CU6.AX Clarity Pharmaceuticals Ltd
2.5100
+0.80%
MSB.AX Mesoblast Limited
1.8100
+1.69%
NEU.AX Neuren Pharmaceuticals Limited
13.19
+0.04%